ArticleFrontiers in immunology2026

ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.

Emily Voigt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.